Literature DB >> 15846271

Comparative efficacy of monophasic and biphasic waveforms for transthoracic cardioversion of atrial fibrillation and atrial flutter.

Osnat T Gurevitz1, Naser M Ammash, Joseph F Malouf, Krishnaswamy Chandrasekaran, Ana Gabriela Rosales, Karla V Ballman, Stephen C Hammill, Roger D White, Bernard J Gersh, Paul A Friedman.   

Abstract

BACKGROUND: Transthoracic cardioversion fails to restore sinus rhythm in 6% to 33% of patients with atrial fibrillation. This study sought to determine the relative efficacy of biphasic waveforms compared with monophasic waveforms in the treatment of atrial arrhythmias.
METHODS: A total of 912 patients underwent 1022 transthoracic cardioversions between May 2000 and December 2001. A monophasic damped sine waveform was used in the first 304 cases, and a rectilinear biphasic defibrillator was used in the next 718 cases.
RESULTS: Use of a biphasic waveform was associated with 94% success in conversion to sinus rhythm compared with 84% with a monophasic waveform (P < .001). The cumulative energy required to restore sinus rhythm was lower with biphasic shocks in both atrial fibrillation and atrial flutter groups (554 +/- 413 J for monophasic vs 199 +/- 216 J for biphasic shocks in the atrial fibrillation group, P < .001; 251 +/- 302 J vs 108 +/- 184 J, respectively, in the atrial flutter group, P < .001). In a multivariate analysis, use of a biphasic shock was associated with a 3.9-fold increase in success of cardioversion.
CONCLUSION: When used to cardiovert atrial arrhythmias, the rectilinear biphasic waveform was associated with higher success rates and lower cumulative energies than the monophasic damped sine waveform.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15846271     DOI: 10.1016/j.ahj.2004.07.007

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

Review 1.  [Electrical and pharmacological strategies for early cardioversion of atrial fibrillation].

Authors:  M Linhart; T Lewalter
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006-06

2.  Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis.

Authors:  Edward A El-Am; Angela Dispenzieri; Rowlens M Melduni; Naser M Ammash; Roger D White; David O Hodge; Peter A Noseworthy; Grace Lin; Sorin V Pislaru; Alexander C Egbe; Martha Grogan; Vuyisile T Nkomo
Journal:  J Am Coll Cardiol       Date:  2019-02-12       Impact factor: 24.094

Review 3.  Ventricular fibrillation and defibrillation.

Authors:  P Jones; N Lodé
Journal:  Arch Dis Child       Date:  2007-10       Impact factor: 3.791

4.  Real-Time Pathophysiologic Correlates of Left Atrial Appendage Thrombus in Patients Who Underwent Transesophageal-Guided Electrical Cardioversion for Atrial Fibrillation.

Authors:  Rowlens M Melduni; Bernard J Gersh; Waldemar E Wysokinski; Naser M Ammash; Paul A Friedman; David O Hodge; Krishnaswamy Chandrasekaran; Jae K Oh; Hon-Chi Lee
Journal:  Am J Cardiol       Date:  2018-03-13       Impact factor: 2.778

5.  Cardioversion of Atrial Fibrillation and Flutter: Comparative Study of Pulsed vs. Low Energy Biphasic Truncated Exponential Waveforms.

Authors:  Delphine Lavignasse; Elina Trendafilova; Elena Dimitrova; Vessela Krasteva
Journal:  J Atr Fibrillation       Date:  2019-10-31

6.  The role of biphasic shocks for transthoracic cardioversion of atrial fibrillation.

Authors:  Simon J Walsh; Ben M Glover; A A Jennifer Adgey
Journal:  Indian Pacing Electrophysiol J       Date:  2005-10-01

7.  Risk Factors for Failure of Direct Current Cardioversion in Patients with Type 2 Diabetes Mellitus and Atrial Fibrillation.

Authors:  Handrean Soran; Moulinath Banerjee; Jamal B Mohamad; Safwaan Adam; Jan Hoong Ho; Shakawan M Ismaeel; Shaishav Dhage; Akheel A Syed; Ibrahem M A Abdulla; Naveed Younis; Rayaz A Malik
Journal:  Biomed Res Int       Date:  2018-03-12       Impact factor: 3.411

8.  Facilitated electrical cardioversion: does the selection of the antiarrhythmic drug matter?

Authors:  Gheorghe-Andrei Dan; Dobromir Dobrev
Journal:  Int J Cardiol Heart Vasc       Date:  2019-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.